Literature DB >> 1362356

The molecular study of bacterial virulence: a review of current approaches, illustrated by the study of adhesion in uropathogenic Escherichia coli.

R J Roche1, E R Moxon.   

Abstract

Pathogenic bacteria coexist with their hosts in a relationship which most frequently allows persistence of the bacteria without causing disease. In a small proportion of colonised individuals the complex mutual interaction between microbe and host is upset, leading to disease in the host. The investigation of bacterial virulence determinants and their genetic control at the molecular level is an important facet of the development of strategies to combat disease. This review focuses on the investigation of a single pathogenic organism as a means of illustrating modern approaches to the investigation of bacterial virulence. The importance of uropathogenic Escherichia coli in causing acute and recurrent pyelonephritis with the consequent morbidity of chronic renal failure is well established. Pyelonephritis-associated (Pap) pili are likely to be critical virulence factors in uropathogenic E. coli. The evidence for their role in pathogenicity and the control of their expression at the molecular genetic level is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362356     DOI: 10.1007/bf00866514

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  46 in total

1.  Properties of Escherichia coli in patients with renal scarring.

Authors:  H Lomberg; M Hellström; U Jodal; I Orskov; C Svanborg Edén
Journal:  J Infect Dis       Date:  1989-03       Impact factor: 5.226

2.  Molecular structure of the Dr adhesin: nucleotide sequence and mapping of receptor-binding domain by use of fusion constructs.

Authors:  T N Swanson; S S Bilge; B Nowicki; S L Moseley
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

3.  Escherichia coli pili as possible mediators of attachment to human urinary tract epithelial cells.

Authors:  C S Edén; H A Hansson
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

4.  Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis.

Authors:  V Väisänen; J Elo; L G Tallgren; A Siitonen; P H Mäkelä; C Svanborg-Edén; G Källenius; S B Svenson; H Hultberg; T Korhonen
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

5.  Occurrence of P-fimbriated Escherichia coli in urinary tract infections.

Authors:  G Källenius; R Möllby; S B Svenson; I Helin; H Hultberg; B Cedergren; J Winberg
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

6.  Structure and antigenic properties of the tip-located P pilus proteins of uropathogenic Escherichia coli.

Authors:  B Lund; F Lindberg; S Normark
Journal:  J Bacteriol       Date:  1988-04       Impact factor: 3.490

7.  Correlation of P blood group, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis.

Authors:  H Lomberg; L A Hanson; B Jacobsson; U Jodal; H Leffler; C S Edén
Journal:  N Engl J Med       Date:  1983-05-19       Impact factor: 91.245

8.  Frequency of E. coli K antigens in urinary-tract infections in children.

Authors:  B Kaijser; L A Hanson; U Jodal; G Lidin-Janson; J B Robbins
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

9.  Transcriptional activation of a pap pilus virulence operon from uropathogenic Escherichia coli.

Authors:  M Båga; M Göransson; S Normark; B E Uhlin
Journal:  EMBO J       Date:  1985-12-30       Impact factor: 11.598

10.  Genes of pyelonephritogenic E. coli required for digalactoside-specific agglutination of human cells.

Authors:  F P Lindberg; B Lund; S Normark
Journal:  EMBO J       Date:  1984-05       Impact factor: 11.598

View more
  2 in total

Review 1.  Pyelonephritis in pregnancy: an update on treatment options for optimal outcomes.

Authors:  Jennifer A Jolley; Deborah A Wing
Journal:  Drugs       Date:  2010-09-10       Impact factor: 9.546

Review 2.  Pyelonephritis in pregnancy: treatment options for optimal outcomes.

Authors:  D A Wing
Journal:  Drugs       Date:  2001       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.